Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Pharmacological and ethical comparisons of lung cancer medicine accessibility in Australia and New Zealand.
J Med Ethics
August 2024
Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand.
Gaps in funded cancer medicines between New Zealand and Australia can have significant implications for patients and their families. Pharmac, the New Zealand pharmaceutical funding agency, has been criticised for not funding enough cancer medicines, and a 2022 review identified ethical concerns about its utilitarian focus on efficiency. However, as the costs of new cancer medicines rise along with public and political pressure to fund them, questions about value for money remain critical for health systems worldwide.
View Article and Find Full Text PDFEvaluation of Anti-Obesity and Antidiabetic Activities of in Cell and Animal Models.
Pharmaceuticals (Basel)
March 2024
Department of Oriental Pharmac and Wonkwang-Oriental Medicines Research Institute, Wonkwang University, Sinyong-dong, Iksan 570-749, Republic of Korea.
is a popular traditional medicinal herb used in Asian countries. This study is focused on evaluating its role in lipid and glucose metabolism in cell and animal models to establish the plant as an anti-obesity and antidiabetic herb. A butanol fraction of was used in the study.
View Article and Find Full Text PDFAOTMiT reimbursement recommendations compared to other HTA agencies.
Eur J Health Econ
November 2024
Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology (CePT), Medical University of Warsaw, Banacha 1B, 02-097, Warsaw, Poland.
Our objective was to compare AOTMiT (Polish: Agencja Oceny Technologii Medycznych i Taryfikacji) recommendations to other HTA (Health Technology Assessment) agencies for newly registered drugs and new registration indications issued by the European Medicines Agency between 2014 and 2019. The study aims to assess the consistency and justifications of AOTMiT recommendations compared to that of other HTA agencies in 11 countries. A total of 2496 reimbursement recommendations published by 12 HTA agencies for 464 medicinal products and 525 indications were analyzed.
View Article and Find Full Text PDFIs PHARMAC's decision-making fair, cost-effective and clinically effective? Observations from the real world.
N Z Med J
October 2022
Associate Professor of Medicine, Department of Medicine, The University of Auckland, New Zealand.
Nil.
View Article and Find Full Text PDFIs PHARMAC's decision making fair? Findings from an evaluation of decision-making in the New Zealand health system.
N Z Med J
February 2022
Elaine Gurr Professor of General Practice, Department of General Practice and Rural Health, Dunedin School of Medicine, University of Otago, Dunedin.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!